Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience

Abstract

Antimicrotubular agents are associated with CVAEs, especially in combination chemotherapy regimens. Based on this study, we suggest routine cardiovascular assessment of patients with cancer before initiating antimicrotubular agents in combination therapy.